LakeShore Biopharma Co Ltd (LSB)
0.6222
-0.03
(-4.94%)
USD |
NASDAQ |
Jun 25, 16:00
0.6222
0.00 (0.00%)
After-Hours: 20:00
LakeShore Biopharma Enterprise Value: 99.94M for June 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 24, 2024 | 99.94M |
| June 21, 2024 | 94.87M |
| June 20, 2024 | 93.47M |
| June 18, 2024 | 105.57M |
| June 17, 2024 | 103.25M |
| June 14, 2024 | 103.96M |
| June 13, 2024 | 103.37M |
| June 12, 2024 | 106.13M |
| June 11, 2024 | 108.73M |
| June 10, 2024 | 102.31M |
| June 07, 2024 | 109.76M |
| June 06, 2024 | 115.16M |
| June 05, 2024 | 115.34M |
| June 04, 2024 | 115.89M |
| June 03, 2024 | 121.86M |
| May 31, 2024 | 116.74M |
| May 30, 2024 | 122.79M |
| May 29, 2024 | 125.58M |
| May 28, 2024 | 133.02M |
| May 24, 2024 | 133.95M |
| May 23, 2024 | 123.45M |
| May 22, 2024 | 124.55M |
| May 21, 2024 | 130.23M |
| May 20, 2024 | 128.37M |
| May 17, 2024 | 130.04M |
| Date | Value |
|---|---|
| May 16, 2024 | 127.45M |
| May 15, 2024 | 134.88M |
| May 14, 2024 | 130.99M |
| May 13, 2024 | 122.80M |
| May 10, 2024 | 129.30M |
| May 09, 2024 | 127.63M |
| May 08, 2024 | 127.44M |
| May 07, 2024 | 113.48M |
| May 06, 2024 | 110.92M |
| May 03, 2024 | 107.69M |
| May 02, 2024 | 107.71M |
| May 01, 2024 | 108.83M |
| April 30, 2024 | 104.55M |
| April 29, 2024 | 110.69M |
| April 26, 2024 | 113.48M |
| April 25, 2024 | 113.02M |
| April 24, 2024 | 114.41M |
| April 23, 2024 | 114.50M |
| April 22, 2024 | 107.99M |
| April 19, 2024 | 106.54M |
| April 18, 2024 | 118.60M |
| April 17, 2024 | 126.14M |
| April 16, 2024 | 118.49M |
| April 15, 2024 | 121.86M |
| April 12, 2024 | 119.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
73.47M
Minimum
Feb 02 2024
965.65M
Maximum
Mar 17 2023
138.93M
Average
119.29M
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 49.71M |
| Zai Lab Ltd | 1.248B |
| China SXT Pharmaceuticals Inc | -7.959M |
| Adagene Inc | 40.94M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.51M |
| Revenue (Quarterly) | 13.38M |
| Total Expenses (Quarterly) | 27.21M |
| EPS Diluted (Quarterly) | -0.1565 |
| Gross Profit Margin (Quarterly) | 81.92% |
| Profit Margin (Quarterly) | -108.4% |
| Earnings Yield | -63.97% |
| Normalized Earnings Yield | -46.98 |